Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Experimental Hematology|March 4, 2022
Heterozygous Dnmt3a R878C induces expansion of quiescent hematopoietic stem cell poolTakashi Higo, Yutaro Suzuki, Michiaki Sato, et al.
Internal Medicine (Tokyo, Japan)|October 8, 2025
Persistent Unilateral Pleural Effusion with Chimeric Antigen Receptor T-cell Infiltration in Primary Mediastinal Large B-cell LymphomaHiroyoshi Hayashi, Masatoshi Sakurai, Miki Sakamoto, et al.
BMC Cancer|January 4, 2020
TP53 and PTEN mutations were shared in concurrent germ cell tumor and acute megakaryoblastic leukemiaKeiichi Akizuki, Masaaki Sekine, Yasunori Kogure, et al.
Nature|June 5, 2020
Landscape and function of multiple mutations within individual oncogenesYuki Saito, Junji Koya, Mitsugu Araki, et al.
NPJ Precision Oncology|April 4, 2026
Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignanciesZen Tamura, Yuki Saito, Yasunori Kogure, et al.
Leukemia|January 31, 2019
A germline HLTF mutation in familial MDS induces DNA damage accumulation through impaired PCNA polyubiquitinationKensuke Takaoka, Masahito Kawazu, Junji Koya, et al.
BMC Cancer|November 14, 2018
MiR-10a and HOXB4 are overexpressed in atypical myeloproliferative neoplasmsPierre-Yves Dumas, Olivier Mansier, Valerie Prouzet-Mauleon, et al.
Leukemia & Lymphoma|March 12, 2020
Nationwide epidemiological survey of familial myelodysplastic syndromes/acute myeloid leukemia in Japan: a multicenter retrospective studyKensuke Takaoka, Junji Koya, Akihide Yoshimi, et al.
Blood Advances|May 20, 2026
Atezolizumab for relapsed/refractory extranodal NK/T-cell lymphoma: the phase II NCCH1903/ATTACK trialShinichi Makita, Junji Koya, Yasuhiro Suzuki, et al.
Blood Advances|July 17, 2025
In vivo CRISPR screening reveals cooperation of KMT2D and TP53 deficiencies in B-cell lymphomagenesisKentaro Yamaguchi, Junji Koya, Kota Mizuno, et al.
Pageof 4